Primary cutaneous post-transplant lymphoproliferative disorder that rapidly improved upon reduction of immunosuppression and addition of everolimus

Naoko Hattori; Yuta Koike; Yumi Hanatani; Koji Ando; Yasuhiro Maruya; Masaaki Hidaka; Susumu Eguchi; Kouhei Taniguchi; Tadashi Yoshino; Hiroyuki Murota

doi:10.1111/1346-8138.15549

Primary cutaneous post-transplant lymphoproliferative disorder that rapidly improved upon reduction of immunosuppression and addition of everolimus

Naoko Hattori, Yuta Koike, Yumi Hanatani, Koji Ando, Yasuhiro Maruya, Masaaki Hidaka, Susumu Eguchi, Kouhei Taniguchi, Tadashi Yoshino, Hiroyuki Murota

Research output: Contribution to journal › Letter › peer-review

Original language	English
Pages (from-to)	e406-e408
Journal	Journal of Dermatology
Volume	47
Issue number	11
DOIs	https://doi.org/10.1111/1346-8138.15549
Publication status	Published - Nov 1 2020

ASJC Scopus subject areas

Dermatology

Access to Document

10.1111/1346-8138.15549

Cite this

Primary cutaneous post-transplant lymphoproliferative disorder that rapidly improved upon reduction of immunosuppression and addition of everolimus. / Hattori, Naoko; Koike, Yuta; Hanatani, Yumi; Ando, Koji; Maruya, Yasuhiro; Hidaka, Masaaki; Eguchi, Susumu; Taniguchi, Kouhei; Yoshino, Tadashi; Murota, Hiroyuki.

In: Journal of Dermatology, Vol. 47, No. 11, 01.11.2020, p. e406-e408.

Research output: Contribution to journal › Letter › peer-review

Hattori, Naoko ; Koike, Yuta ; Hanatani, Yumi ; Ando, Koji ; Maruya, Yasuhiro ; Hidaka, Masaaki ; Eguchi, Susumu ; Taniguchi, Kouhei ; Yoshino, Tadashi ; Murota, Hiroyuki. / Primary cutaneous post-transplant lymphoproliferative disorder that rapidly improved upon reduction of immunosuppression and addition of everolimus. In: Journal of Dermatology. 2020 ; Vol. 47, No. 11. pp. e406-e408.

@article{32ebb9a1b1b746a7a5fa17d9295e1023,

title = "Primary cutaneous post-transplant lymphoproliferative disorder that rapidly improved upon reduction of immunosuppression and addition of everolimus",

author = "Naoko Hattori and Yuta Koike and Yumi Hanatani and Koji Ando and Yasuhiro Maruya and Masaaki Hidaka and Susumu Eguchi and Kouhei Taniguchi and Tadashi Yoshino and Hiroyuki Murota",

note = "Funding Information: We express our sincere thanks to Dr Hisamitsu Miyaaki (Department of Gastroenterology and Hepatology, Nagasaki University Graduate School of Biomedical Sciences) for providing anti-mTOR antibody and Professor Shin Morizane (Department of Dermatology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences) for his advice on immunostaining.",

year = "2020",

month = nov,

day = "1",

doi = "10.1111/1346-8138.15549",

language = "English",

volume = "47",

pages = "e406--e408",

journal = "Journal of Dermatology",

issn = "0385-2407",

publisher = "Wiley-Blackwell",

number = "11",

}

TY - JOUR

T1 - Primary cutaneous post-transplant lymphoproliferative disorder that rapidly improved upon reduction of immunosuppression and addition of everolimus

AU - Hattori, Naoko

AU - Koike, Yuta

AU - Hanatani, Yumi

AU - Ando, Koji

AU - Maruya, Yasuhiro

AU - Hidaka, Masaaki

AU - Eguchi, Susumu

AU - Taniguchi, Kouhei

AU - Yoshino, Tadashi

AU - Murota, Hiroyuki

N1 - Funding Information: We express our sincere thanks to Dr Hisamitsu Miyaaki (Department of Gastroenterology and Hepatology, Nagasaki University Graduate School of Biomedical Sciences) for providing anti-mTOR antibody and Professor Shin Morizane (Department of Dermatology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences) for his advice on immunostaining.

PY - 2020/11/1

Y1 - 2020/11/1

UR - http://www.scopus.com/inward/record.url?scp=85089291230&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85089291230&partnerID=8YFLogxK

U2 - 10.1111/1346-8138.15549

DO - 10.1111/1346-8138.15549

M3 - Letter

C2 - 32783275

AN - SCOPUS:85089291230

VL - 47

SP - e406-e408

JO - Journal of Dermatology

JF - Journal of Dermatology

SN - 0385-2407

IS - 11

ER -

Primary cutaneous post-transplant lymphoproliferative disorder that rapidly improved upon reduction of immunosuppression and addition of everolimus

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this